
==== Front
Eye (Lond)
Eye (Lond)
Eye
0950-222X
1476-5454
Nature Publishing Group UK London

38702514
3091
10.1038/s41433-024-03091-4
Comment
Near infrared/ red light therapy a potential countermeasure for mitochondrial dysfunction in spaceflight associated neuro-ocular syndrome (SANS)
http://orcid.org/0000-0001-8999-0212
Waisberg Ethan ew690@cam.ac.uk

1
http://orcid.org/0000-0003-4860-827X
Ong Joshua 2
http://orcid.org/0000-0003-0811-358X
Masalkhi Mouayad 3
Lee Andrew G. 45678910
1 https://ror.org/013meh722 grid.5335.0 0000 0001 2188 5934 Department of Ophthalmology, University of Cambridge, Cambridge, UK
2 https://ror.org/00jmfr291 grid.214458.e 0000 0004 1936 7347 Department of Ophthalmology and Visual Sciences, University of Michigan Kellogg Eye Center, Ann Arbor, MI USA
3 https://ror.org/05m7pjf47 grid.7886.1 0000 0001 0768 2743 School of Medicine, University College Dublin, Dublin, Ireland
4 https://ror.org/027zt9171 grid.63368.38 0000 0004 0445 0041 Department of Ophthalmology, Blanton Eye Institute, Houston Methodist Hospital, Houston, TX USA
5 https://ror.org/027zt9171 grid.63368.38 0000 0004 0445 0041 The Houston Methodist Research Institute, Houston Methodist Hospital, Houston, TX USA
6 https://ror.org/02r109517 grid.471410.7 0000 0001 2179 7643 Departments of Ophthalmology, Neurology, and Neurosurgery, Weill Cornell Medicine, New York, NY USA
7 https://ror.org/016tfm930 grid.176731.5 0000 0001 1547 9964 Department of Ophthalmology, University of Texas Medical Branch, Galveston, TX USA
8 https://ror.org/04twxam07 grid.240145.6 0000 0001 2291 4776 University of Texas MD Anderson Cancer Center, Houston, TX USA
9 grid.264756.4 0000 0004 4687 2082 Texas A&M College of Medicine, Houston, TX USA
10 grid.412584.e 0000 0004 0434 9816 Department of Ophthalmology, The University of Iowa Hospitals and Clinics, Iowa City, IA USA
3 5 2024
3 5 2024
9 2024
38 13 24992501
12 3 2024
5 4 2024
12 4 2024
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by/4.0/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Subject terms

Medical research
Diseases
issue-copyright-statement© The Royal College of Ophthalmologists 2024
==== Body
pmcIntroduction

Spaceflight-associated neuro-ocular syndrome (SANS) is a syndrome know to affect a significant proportion of astronauts during long-duration spaceflight (LDSF). SANS is characterized by optic disc edema [1], hyperopic shifts [2], chorioretinal folds [3] and globe flattening [4]. While the precise etiology of SANS remains incompletely understood, it is hypothesized to be as a result of the unique conditions encountered in the microgravity environment characteristic of LDSF, and heightened radiation exposure [5]. So far, SANS has been associated with alterations in fluid distribution and ocular structural adaptations induced by microgravity conditions [5].

The effects of microgravity and heightened exposure to radiation through galactic cosmic radiation and solar particle events during space missions are recognized in part for their notable influences on mitochondrial function [6]. Recent comprehensive analyses utilizing multi-omics revealed a consistent manifestation of mitochondrial stress during spaceflight [7]. These alterations include disturbances in metabolic pathways and gene regulation, and suggest that mitochondrial dysfunction plays an important role in prolonged space missions and SANS [7]. Oxidative stress emerges from an imbalance between reactive oxygen species (ROS) production and cellular antioxidant capacity [8]. Mitochondria act as both generators and receivers of ROS, and thus any impairment in their function may potentially contribute to the oxidative stress evident in SANS [8].

Retinal photoreceptors have an abundance of mitochondria to enable phagocytosis and outer segment renewal [9]. Retinal ganglion cell axons also have highly concentrations of mitochondria to efficiently transmit visual information from the eye to the brain. Unlike most cell types, neurons have absolute levels of mitochondrial function requirements to survive due to membrane potential generation requirements [10]. Further understanding the possible role of mitochondrial dysfunction in SANS is essential to develop countermeasures to mitigate the ophthalmic risks associated with long-duration spaceflight [11]. Current proposed countermeasures for SANS include intraocular pressure increase with swimming goggles [12], and vision enhancement with augmented reality to restore any visual losses that may occur [13, 14], however these current countermeasures are insufficient at addressing the underlying pathophysiology of SANS.

Red/Near Infrared (NIR) Light Therapy may serve as a non-invasive and side-effect-free countermeasure to improve mitochondrial function during LDSF. NIR/red light therapy is a form of phototherapy that utilizes specific wavelengths of light to promote healing and reduce inflammation [15, 16]. NIR/red light therapy is believed to enhance mitochondrial function via the absorption of photons by mitochondrial chromophores, such as cytochrome c oxidase, contributing to improved cellular respiration and ATP production, and reducing ROS generation [17]. NIR/red light also has known anti-inflammatory properties, which could mitigate inflammation associated with SANS and its impact on ocular tissues [17]. Furthermore, secondary effects can also occur hours following NIR/red light exposure including the dissociation of nitric oxide from its binding site, modification of the ATP pool and an increased mitochondrial intermembrane potential (Fig. 1) [18]. Alterations in ATP levels can affect cyclic adenosine monophosphate levels, intracellular calcium levels and cellular metabolism.Fig. 1 Hypothesized beneficial effects NIR/red light on mitochondrial function.

These beneficial effects may potentially be useful to mitigate the symptoms of spaceflight associated neuro-ocular syndrome.

NIR/red light therapy has previously been shown to have potential in treating a wide variety of ophthalmic diseases that have a mitochondrial dysfunction component, such as: age related macular degeneration [19], diabetic macular edema [20], myopia [21], dry eye disease [22] and retinitis pigmentosa [23]. NIR/red light therapy has also been shown to improve the normal decline in mitochondrial function that is associated with aging, with a recent study finding improved contrast sensitivity for the tritan axis in participants aged 40-years-old and above treated with 670 nm light [24]. Another study conducted on healthy participants aged 55 years-and-older found that treatment with 670 nm light led to significant improvements in scotopic thresholds, but did not significantly alter visual acuity, low luminance visual acuity, rod-intercept time and no structural alterations on OCT [25].

While promising, the efficacy of red/NIR light therapy for SANS requires further investigation. Many of the existing studies involve smaller sample sizes and several of these studies lack control groups. Factors such as optimal light parameters, treatment duration, and long-term effects need to be carefully evaluated in order to develop standardized protocols for space missions. Moreover, integrating red/NIR light therapy into the comprehensive management of SANS alongside other interventions may offer a synergistic approach to mitigating ocular complications in astronauts. Finally, further research is required to fully understand the subtle functional and structural changes that occur in the eye during LDSF, to fully understand how to mitigate these effects [26, 27].

Author contributions

EW—Conceptualization, Writing. JO—Conceptualization, Writing. MM—Conceptualization, Writing. AGL—Review, Intellectual Support.

Competing interests

The authors declare no competing interests.

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
==== Refs
References

1. Waisberg E Ong J Lee AG Factors associated with optic disc edema development during spaceflight JAMA Ophthalmol 2023 10.1001/jamaophthalmol.2023.0303 36928752
Waisberg E, Ong J, Lee AG. Factors associated with optic disc edema development during spaceflight. JAMA Ophthalmol. 2023. 10.1001/jamaophthalmol.2023.0303.36928752 10.1001/jamaophthalmol.2023.0303
2. Ong J Waisberg E Masalkhi M Kamran SA Lowry K Sarker P Artificial intelligence frameworks to detect and investigate the pathophysiology of spaceflight associated neuro-ocular syndrome (SANS) Brain Sci. 2023 13 1148 10.3390/brainsci13081148 37626504
Ong J, Waisberg E, Masalkhi M, Kamran SA, Lowry K, Sarker P, et al. Artificial intelligence frameworks to detect and investigate the pathophysiology of spaceflight associated neuro-ocular syndrome (SANS). Brain Sci. 2023;13:1148. 10.3390/brainsci13081148.37626504 10.3390/brainsci13081148
3. Masalkhi M Ong J Waisberg E Lee AG Chorioretinal folds in astronauts: risk of chorioretinal fold-related maculopathy and terrestrial staging of disease Eye 2023 10.1038/s41433-023-02730-6 38135772
Masalkhi M, Ong J, Waisberg E, Lee AG. Chorioretinal folds in astronauts: risk of chorioretinal fold-related maculopathy and terrestrial staging of disease. Eye. 2023. 10.1038/s41433-023-02730-6.38135772 10.1038/s41433-023-02730-6
4. Soares B, Ong J, Osteicoechea D, Kadipasaoglu CM, Waisberg E, Sarker P, et al. A potential compensatory mechanism for spaceflight associated neuro-ocular changes from microgravity: current understanding and future directions. Eye. 2024:s41433-024-02952-2. 10.1038/s41433-024-02952-2.
5. Lee AG Mader TH Gibson CR Spaceflight associated neuro-ocular syndrome (SANS) and the neuro-ophthalmologic effects of microgravity: a review and an update npj Microgravity 2020 6 1 10 10.1038/s41526-020-0097-9 31934612
Lee AG, Mader TH, Gibson CR, et al. Spaceflight associated neuro-ocular syndrome (SANS) and the neuro-ophthalmologic effects of microgravity: a review and an update. npj Microgravity. 2020;6:1–10. 10.1038/s41526-020-0097-9.31934612 10.1038/s41526-020-0097-9
6. Nguyen HP Tran PH Kim KS Yang SG The effects of real and simulated microgravity on cellular mitochondrial function npj Microgravity 2021 7 44 10.1038/s41526-021-00171-7 34750383
Nguyen HP, Tran PH, Kim KS, Yang SG. The effects of real and simulated microgravity on cellular mitochondrial function. npj Microgravity. 2021;7:44. 10.1038/s41526-021-00171-7.34750383 10.1038/s41526-021-00171-7
7. Da Silveira WA Fazelinia H Rosenthal SB Laiakis EC Kim MS Meydan C Comprehensive multi-omics analysis reveals mitochondrial stress as a central biological hub for spaceflight impact Cell 2020 183 1185 1201.e20 10.1016/j.cell.2020.11.002 33242417
Da Silveira WA, Fazelinia H, Rosenthal SB, Laiakis EC, Kim MS, Meydan C, et al. Comprehensive multi-omics analysis reveals mitochondrial stress as a central biological hub for spaceflight impact. Cell. 2020;183:1185–1201.e20. 10.1016/j.cell.2020.11.002.33242417 10.1016/j.cell.2020.11.002
8. Ocular oxidative changes and antioxidant therapy during spaceflight | Eye. Accessed November 30, 2023. https://www.nature.com/articles/s41433-023-02841-0.
9. Wang J Deretic D Molecular complexes that direct rhodopsin transport to primary cilia Prog Retinal Eye Res 2014 38 1 19 10.1016/j.preteyeres.2013.08.004
Wang J, Deretic D. Molecular complexes that direct rhodopsin transport to primary cilia. Prog Retinal Eye Res. 2014;38:1–19. 10.1016/j.preteyeres.2013.08.004.10.1016/j.preteyeres.2013.08.004
10. Osborne NN Álvarez CN Del Olmo Aguado S Targeting mitochondrial dysfunction as in aging and glaucoma Drug Discov Today 2014 19 1613 22 10.1016/j.drudis.2014.05.010 24880106
Osborne NN, Álvarez CN, Del Olmo Aguado S. Targeting mitochondrial dysfunction as in aging and glaucoma. Drug Discov Today. 2014;19:1613–22. 10.1016/j.drudis.2014.05.010.24880106 10.1016/j.drudis.2014.05.010
11. Waisberg E Ong J Masalkhi M Mao XW Beheshti A Lee AG Mitochondrial dysfunction in Spaceflight Associated Neuro-Ocular Syndrome (SANS): a molecular hypothesis in pathogenesis Eye 2024 10.1038/s41433-024-02951-3 39043818
Waisberg E, Ong J, Masalkhi M, Mao XW, Beheshti A, Lee AG. Mitochondrial dysfunction in Spaceflight Associated Neuro-Ocular Syndrome (SANS): a molecular hypothesis in pathogenesis. Eye. 2024. 10.1038/s41433-024-02951-3.39043818 10.1038/s41433-024-02951-3
12. Waisberg E, Ong J, Masalkhi M, Paladugu P, Lee AG, Berdahl J. Precisional modulation of translaminar pressure gradients for ophthalmic diseases. Eur J Ophthalmol. 2023:11206721231199779. 10.1177/11206721231199779.
13. Ong J Zaman N Waisberg E Kamran SA Lee AG Tavakkoli A Head-mounted digital metamorphopsia suppression as a countermeasure for macular-related visual distortions for prolonged spaceflight missions and terrestrial health Wearable Technol 2022 3 e26 10.1017/wtc.2022.21 38486901
Ong J, Zaman N, Waisberg E, Kamran SA, Lee AG, Tavakkoli A. Head-mounted digital metamorphopsia suppression as a countermeasure for macular-related visual distortions for prolonged spaceflight missions and terrestrial health. Wearable Technol. 2022;3:e26. 10.1017/wtc.2022.21.38486901 10.1017/wtc.2022.21
14. Waisberg E Ong J Zaman N Paladugu P Kamran SA Tavakkoli A The spaceflight contrast sensitivity hypothesis and its role to investigate the pathophysiology of spaceflight-associated neuro-ocular syndrome Front Ophthalmol 2023 3 1229748 10.3389/fopht.2023.1229748
Waisberg E, Ong J, Zaman N, Paladugu P, Kamran SA, Tavakkoli A, et al. The spaceflight contrast sensitivity hypothesis and its role to investigate the pathophysiology of spaceflight-associated neuro-ocular syndrome. Front Ophthalmol. 2023;3:1229748. 10.3389/fopht.2023.1229748.10.3389/fopht.2023.1229748
15. Tsai SR Hamblin MR Biological effects and medical applications of infrared radiation J Photochem Photobiol B: Biol 2017 170 197 207 10.1016/j.jphotobiol.2017.04.014
Tsai SR, Hamblin MR. Biological effects and medical applications of infrared radiation. J Photochem Photobiol B: Biol. 2017;170:197–207. 10.1016/j.jphotobiol.2017.04.014.10.1016/j.jphotobiol.2017.04.014
16. The role of near-infrared light-emitting diodes in aging adults related to inflammation. Healthy Aging Res. 10.12715/har.2015.4.24.
17. Arranz-Paraíso D Sola Y Baeza-Moyano D Benítez-Martínez M Melero-Tur S González-Lezcano RA Mitochondria and light: An overview of the pathways triggered in skin and retina with incident infrared radiation J Photochem Photobiol B: Biol 2023 238 112614 10.1016/j.jphotobiol.2022.112614
Arranz-Paraíso D, Sola Y, Baeza-Moyano D, Benítez-Martínez M, Melero-Tur S, González-Lezcano RA. Mitochondria and light: An overview of the pathways triggered in skin and retina with incident infrared radiation. J Photochem Photobiol B: Biol. 2023;238:112614. 10.1016/j.jphotobiol.2022.112614.10.1016/j.jphotobiol.2022.112614
18. Gonzalez-Lima F, Rojas. Low-level light therapy of the eye and brain. EB. Published online October 2011:49. 10.2147/EB.S21391.
19. Burton B Parodi MB Jürgens I Zanlonghi X Hornan D Roider J LIGHTSITE II randomized multicenter trial: evaluation of multiwavelength photobiomodulation in non-exudative age-related macular degeneration Ophthalmol Ther 2023 12 953 68 10.1007/s40123-022-00640-6 36588113
Burton B, Parodi MB, Jürgens I, Zanlonghi X, Hornan D, Roider J, et al. LIGHTSITE II randomized multicenter trial: evaluation of multiwavelength photobiomodulation in non-exudative age-related macular degeneration. Ophthalmol Ther. 2023;12:953–68. 10.1007/s40123-022-00640-6.36588113 10.1007/s40123-022-00640-6
20. Tang J Herda AA Kern TS Photobiomodulation in the treatment of patients with non-center-involving diabetic macular oedema Br J Ophthalmol 2014 98 1013 5 10.1136/bjophthalmol-2013-304477 24682183
Tang J, Herda AA, Kern TS. Photobiomodulation in the treatment of patients with non-center-involving diabetic macular oedema. Br J Ophthalmol. 2014;98:1013–5. 10.1136/bjophthalmol-2013-304477.24682183 10.1136/bjophthalmol-2013-304477
21. Jiang Y Zhu Z Tan X Kong X Zhong H Zhang J Effect of repeated low-level red-light therapy for myopia control in children Ophthalmology 2022 129 509 19 10.1016/j.ophtha.2021.11.023 34863776
Jiang Y, Zhu Z, Tan X, Kong X, Zhong H, Zhang J, et al. Effect of repeated low-level red-light therapy for myopia control in children. Ophthalmology. 2022;129:509–19. 10.1016/j.ophtha.2021.11.023.34863776 10.1016/j.ophtha.2021.11.023
22. Giannaccare G Vaccaro S Pellegrini M Borselli M Carnovale Scalzo G Taloni A Serial sessions of a novel low-level light therapy device for home treatment of dry eye disease Ophthalmol Ther 2023 12 459 68 10.1007/s40123-022-00619-3 36484948
Giannaccare G, Vaccaro S, Pellegrini M, Borselli M, Carnovale Scalzo G, Taloni A, et al. Serial sessions of a novel low-level light therapy device for home treatment of dry eye disease. Ophthalmol Ther. 2023;12:459–68. 10.1007/s40123-022-00619-3.36484948 10.1007/s40123-022-00619-3
23. Ivandic BT Ivandic T Low-level laser therapy improves vision in a patient with retinitis pigmentosa Photomed Laser Surg 2014 32 181 4 10.1089/pho.2013.3535 24527959
Ivandic BT, Ivandic T. Low-level laser therapy improves vision in a patient with retinitis pigmentosa. Photomed Laser Surg. 2014;32:181–4. 10.1089/pho.2013.3535.24527959 10.1089/pho.2013.3535
24. Shinhmar H Grewal M Sivaprasad S Hogg C Chong V Neveu M Optically improved mitochondrial function redeems aged human visual decline. Le Couteur D, ed J Gerontology: Ser A 2020 75 e49 e52 10.1093/gerona/glaa155
Shinhmar H, Grewal M, Sivaprasad S, Hogg C, Chong V, Neveu M, et al. Optically improved mitochondrial function redeems aged human visual decline. Le Couteur D, ed. J Gerontology: Ser A. 2020;75:e49–e52. 10.1093/gerona/glaa155.10.1093/gerona/glaa155
25. Grewal MK Sivapathasuntharam C Chandra S Gurudas S Chong V Bird A A pilot study evaluating the effects of 670 nm photobiomodulation in healthy ageing and age-related macular degeneration JCM 2020 9 1001 10.3390/jcm9041001 32252424
Grewal MK, Sivapathasuntharam C, Chandra S, Gurudas S, Chong V, Bird A, et al. A pilot study evaluating the effects of 670 nm photobiomodulation in healthy ageing and age-related macular degeneration. JCM. 2020;9:1001. 10.3390/jcm9041001.32252424 10.3390/jcm9041001
26. Masalkhi M Ong J Waisberg E Lee AG Deep learning in ophthalmic and orbital ultrasound for spaceflight associated neuro-ocular syndrome (SANS) Eye 2023 10.1038/s41433-023-02877-2 38135772
Masalkhi M, Ong J, Waisberg E, Lee AG. Deep learning in ophthalmic and orbital ultrasound for spaceflight associated neuro-ocular syndrome (SANS). Eye. 2023. 10.1038/s41433-023-02877-2.38135772 10.1038/s41433-023-02877-2
27. Waisberg E, Ong J, Masalkhi M, Lee AG. Anemia and spaceflight associated neuro-ocular syndrome (SANS). Prehosp Disaster Med. Published online July 31, 2023:1-3. 10.1017/S1049023X23006131.
